4070 Inorganic Chemistry, Vol. 39, No. 18, 2000
Lam et al.
[(iPr3TACD)Cu(CH3CN)]SbF6. In the glovebox, solid [Cu(CH3-
CN)4]SbF6 (0.172 g, 0.371 mmol) was added to a stirred solution of
iPr3TACD (0.100 g, 0.372 mmol) in CH3CN (2 mL). The solution was
stirred for 30 min before being added to Et2O (20 mL), which resulted
in the deposition of the product as a white powder (0.181 g, 80%). 1H
NMR (CD3CN, 500 MHz): δ 1.19 (d, J ) 6.5 Hz, 6H), 1.20 (d, J )
6.5 Hz, 6H), 1.21 (d, J ) 6.5 Hz, 6H), 1.58-1.70 (m, 1H), 1.88-2.00
(m, 4H), 2.50-2.64 (m, 6H), 2.76-2.98 (m, 6H), 3.0 (h, J ) 6.5 Hz,
2H), 3.1 (h, J ) 6.5 Hz, 1H) ppm. 13C{1H} NMR (CD2Cl2, 75 MHz):
δ 58.6, 55.2, 51.9, 50.1, 28.4, 18.9, 18.6, 18.3, 2.7 ppm (observed 9
out of 11 expected signals). FTIR (KBr, cm-1): 2980, 2911, 2883,
2853, 2267 (CtN), 1495, 1472, 1461, 1376, 1270, 1183, 1161, 1147,
1123, 1071, 1032, 955, 937, 738, 658 (SbF6-). FAB-MS (MNBA):
m/e (relative intensity) 373 ([M - SbF6]+, 3), 332 ([M - CH3CN -
SbF6]+, 100). Anal. Calcd for CuC18H38N4SbF6: C, 35.45; H, 6.28; N,
9.19. Found: C, 35.65; H, 6.48; N, 9.14. [(iPr3TACD)Cu(CH3CN)]-
ClO4 was prepared analogously to [(iPr3TACD)Cu(CH3CN)]SbF6,
X-ray-quality crystals were obtained with the similarly prepared
perchlorate salt by using CH2Cl2/Et2O (vapor diffusion).
[(iPr3TACD)Cu(CO)]SbF6. Solid [(iPr3TACD)Cu(CH3CN)]SbF6
(0.063 g, 0.103 mmol) was dissolved in acetone (5 mL) in a Schlenk
flask. Carbon monoxide was bubbled through the light yellow solution
for 5 min. After the solution was allowed to equilibrate for an additional
10 min, the solvent was removed under reduced pressure, yielding a
white powder. The product was reprecipitated from acetone/Et2O (1:
1
20) to give a white powder (0.053 g, 85%). H NMR (CD2Cl2, 300
MHz): δ 1.27 (d, J ) 6.6 Hz, 6H), 1.30 (d, J ) 6.6 Hz, 6H), 1.33 (d,
J ) 6.6 Hz, 6H), 1.73-1.86 (m, 1H), 1.98-2.14 (m, 1H), 2.64-2.82
(m, 6H), 2.92-3.08 (m, 6H), 3.17 (h, J ) 6.6 Hz, 2H), 3.23 (h, J )
6.6 Hz, 2H) ppm. 13C{1H} NMR (CD2Cl2, 75 MHz): δ 60.4, 56.8,
53.1, 52.9, 51.0, 27.2, 20.2, 19.3, 18.2 ppm (observed 9 out of 10
expected signals). FTIR (KBr, cm-1): 2980, 2939, 2879, 2063 (Ct
O), 1494, 1465, 1393, 1377, 1349, 1214, 1178, 1142, 1063, 1035, 915,
864, 746, 707, 657 (SbF6). Anal. Calcd for CuN3C17H35OSbF6: C,
34.21; H, 5.88; N, 7.04. Found: C, 33.64; H, 5.77; N, 7.12.
1
except by using [Cu(CH3CN)4]ClO4 (81%). H NMR (CD3CN, 300
MHz): δ 1.18 (d, J ) 6.6 Hz, 6H), 1.19 (d, J ) 6.6 Hz, 6H), 1.22 (d,
J ) 6.6 Hz, 6H), 1.58-1.70 (m, 1H), 1.88-2.00 (m, 4H), 2.50-2.64
(m, 6H), 2.76-2.98 (m, 6H), 3.0 (h, J ) 3.9 Hz, 2H), 3.1 (h, J ) 3.9
Hz, 1H) ppm.
[(Me3TACD)Cu(CO)]SbF6. This compound was prepared analo-
gously to [(iPr3TACD)Cu(CO)]SbF6, except by using [(Me3TACD)-
Cu(CH3CN)]SbF6 (84%). 1H NMR (CD2Cl2, 500 MHz): δ 1.78-1.82
(m, 1H), 2.07-2.16 (m, 1H), 2.46-2.52 (m, 2H), 2.75 (s, 6H), 2.80-
2.85 (m, 4H), 2.88 (s, 3H), 2.98-3.06 (m, 6H) ppm. 13C{1H} NMR
(CD2Cl2, 75 MHz): δ 58.9, 57.0, 55.1, 50.8, 50.7, 24.3 ppm (observed
6 out of 7 expected signals). FTIR (KBr, cm-1): 2949, 2880, 2086
(CtO), 1474, 1365, 1262, 1106, 1065, 1032, 762, 658 (SbF6). Anal.
Calcd for CuN3C11H23OSbF6: C, 25.77; H, 4.52; N, 8.20. Found: C,
25.96; H, 4.52; N, 8.13.
[(Bn3TACD)Cu(CO)]SbF6. This compound was prepared analo-
gously to [(iPr3TACD)Cu(CO)]SbF6, except by using [(Bn3TACD)-
Cu(CH3CN)]SbF6 (91%). 1H NMR (CD2Cl2, 500 MHz): δ 1.74-1.88
(m, 1H), 1.96-2.18 (m, 1H), 2.62-2.76 (m, 4H), 2.76-2.96 (m, 4H),
2.08-3.32 (m, 4H), 3.83 (s, 2H), 2.86 (s, 4H), 7.12-7.24 (m, 4H),
7.32-7.48 (m, 8H), 7.48-7.54 (m, 3H) ppm. 13C{1H} NMR (CD2Cl2,
75 MHz): δ 134.9, 132.29, 131.6, 131.5, 129.3, 129.1, 128.9, 128.7,
65.8, 64.9, 56.1, 55.4, 49.8, 23.5 (observed 14 out of 15 expected
signals). FTIR (KBr, cm-1): 3061, 3032, 2931, 2872, 2358, 2074 (Ct
O), 1499, 1456, 1348, 1204, 1072, 1038, 975, 916, 762, 743, 707, 657
(SbF6). Anal. Calcd for CuN3C29H35OSbF6: C, 47.01; H, 4.76; N, 5.67.
Found: C, 47.75; H, 4.94; N, 5.82.
[(iPr3TACN)Cu(CH3CN)]BPh4. A solution of CuCl (0.20 g, 2.00
mmol) in CH3CN (5 mL) was treated with a solution of iPr3TACN
(0.52 g, 2.04 mmol) in THF (3 mL). After stirring the colorless solution
for 30 min, a solution of NaBPh4 (0.68 g, 1.99 mmol) in CH3CN (5
mL) was added, causing the precipitation of NaCl. After stirring for
an additional 30 min the mixture was filtered through a pad of Celite
and the filtrate treated with Et2O (20 mL). Storage at -20 °C caused
the deposition of colorless plate crystals of the product (1.09 g, 80%).
1H NMR (500 MHz, CD2Cl2): δ 7.34-7.32 (m, 8H), 7.04 (t, J ) 6.5
Hz, 8H), 6.89 (t, J ) 7.5 Hz, 4H), 3.05 (heptet, J ) 6.5 Hz, 3H),
2.79-2.72 (m, 6H), 2.48-2.42 (m, 6H), 1.94 (s, 3H), 1.20 (d, J ) 6.5
Hz, 18H) ppm. 13C{1H} NMR (125 MHz, CD2Cl2): δ 164.6, 135.4,
126.2, 126.1, 122.2, 58.6, 51.2, 20.0, 3.2 ppm. FTIR (KBr, cm-1): 2265
(CtN), 734 (BPh4-), 704 (BPh4-). Anal. Calcd for C41H56N4BCu: C,
72.50; H, 8.31; N, 8.25. Found: C, 72.13; H, 8.33; N, 8.33.
Reactions of the Cu(I) Complexes with Dioxygen. Dry O2 was
bubbled through a precooled solution of [(iPr3TACD)Cu(CH3CN)]X
(X ) SbF6-, ClO4-, or BPh4-) in CH2Cl2, acetone, or THF, [(Me3-
TACD)Cu(CH3CN)]X (X ) SbF6-, ClO4-) in CH2Cl2 or THF, or [(Bn3-
TACD)Cu(CH3CN)]SbF6 in CH2Cl2, THF, or acetone. The time
required for full oxygenation, as indicated by maximization of the
absorbance bands associated with the product(s), differed, with [(iPr3-
TACD)Cu(CH3CN)]X requiring 1 h of vigorous O2 bubbling and [(Me3-
TACD)Cu(CH3CN)]X and [(Bn3TACD)Cu(CH3CN)]SbF6 requiring
only 5 min. Spectroscopic properties of the oxygenation products are
listed in Table 3. The extinction coefficients of the UV-vis features
were obtained from Beer’s law plots (concentration ranges for the cases
with iPr3TACD ) 0.16-0.60 mM; Me3TACD ) 0.04-0.17 mM; Bn3-
TACD ) 0.02-0.25 mM). Samples for resonance Raman spectroscopy
were prepared by first dissolving the Cu(I) complex in the desired
solvent (∼5 mM) in a Schlenk flask. After cooling to -80 °C, dry O2
[(d21-iPr3TACD)Cu(CH3CN)]BPh4. In the glovebox, solid NaBPh4
(0.158 g, 0.462 mmol) was added to a stirred solution of d21-iPr3TACD
(0.149 g, 0.514 mmol) and CuCl (0.046 g, 0.465 mmol) in CH3CN (2
mL). After the cloudy white solution had been stirred for 30 min, it
was filtered through a Celite pad. Additional CH3CN (5 mL) was used
to wash the Celite pad, and the combined filtrates were brought to
dryness under reduced pressure, yielding a white powder. Recrystal-
lization with CH3CN/Et2O (1:20) gave white feathery crystals (0.317
g, 86%). 1H NMR (CD2Cl2, 300 MHz): δ 1.62-1.72 (m, 1H), 1.83-
1.97 (m, 4H), 2.47-2.58 (m, 6H), 2.73-2.94 (m, 6H), 6.91 (t, J ) 7.2
Hz, 4H), 7.06 (t, J ) 7.2 Hz, 8H), 7.32-7.38 (m, 8H) ppm. 13C{1H}
NMR (CD2Cl2, 75 MHz): δ 164.1, 135.9, 125.6, 121.7, 51.9, 50.1,
41.7, 29.9, 21.6, 17.9, 17.0, 2.3 ppm (observed 12 out of 15 expected
signals). FTIR (KBr, cm-1): 3054, 3037, 2983, 2927, 2853, 2259 (Ct
N), 2244, 1582, 1480, 1457, 1429, 1295, 1213, 1185, 1147, 1051, 845,
742, 729 (BPh4-), 702 (BPh4-), 604. FAB-MS (MNBA) m/e (relative
intensity) 394 ([M - BPh4]+, 2), 248 ([M - CH3CN - BPh4]+, 100).
[(Me3TACD)Cu(CH3CN)]SbF6. In the glovebox, solid [Cu(CH3-
CN)4]SbF6 (0.060 g, 0.11 mmol) was added to a stirred solution of
Me3TACD (0.030 g, 0.16 mmol) in CH3CN (2 mL). After the solution
had been stirred for 10 min, it was added to Et2O (20 mL), resulting in
1
the precipitation of the product as a white powder (0.053 g, 78%). H
NMR (CD2Cl2, 500 MHz): δ 1.68-1.76 (m, 1H), 1.94-2.04 (m, 1H),
2.20 (s, 3H), 2.40-2.46 (m, 2H), 2.58 (s, 6H), 2.64-2.74 (m, 7H),
2.74-2.90 (m, 6H) ppm. 13C{1H} NMR (CD2Cl2, 75 MHz): δ 59.0,
55.8, 55.3, 49.2, 48.9, 25.7, 2.6 ppm (observed 7 out of 8 expected
signals). FTIR (KBr, cm-1): 2971, 2866, 2813, 2362, 2342, 2266 (Ct
N), 1494, 1468, 1367, 1273, 1042, 768, 662 (SbF6-). FAB-MS
(MNBA): m/e (relative intensity) 289 ([M - SbF6]+, 10), 248 ([M -
CH3CN - SbF6]+, 100). X-ray-quality crystals were obtained with the
perchlorate salt, which was synthesized in a similar fashion.
[(Bn3TACD)Cu(CH3CN)]SbF6. This was prepared analogously to
[(iPr3TACD)Cu(CH3CN)]SbF6, except by using Bn3TACD (72%) in
CH2Cl2. The light yellow solid was further purified by recrystallization
from CH2Cl2/Et2O (1:20). 1H NMR (CD2Cl2, 300 MHz): δ 1.66-1.79
(m. 1H), 1.90-2.60 (m, 1H), 2.23 (s, 3H), 2.40-2.58 (m, 4H), 2.62-
2.88 (m, 6H), 3.06-3.20 (m, 2H), 3.67 (s, 2H), 3.78 (s, 4H), 7.24-
7.31 (m, 4H), 7.37-7.47 (m, 11H) ppm. 13C{1H} NMR (CD2Cl2, 75
MHz): δ 135.5, 133.5, 131.4, 131.1, 128.6, 128.4, 128.3, 65.1, 63.8,
56.3, 54.6, 49.7, 24.7, 2.87 ppm (observed 14 out of 16 expected
signals). Anal. Calcd for CuC30H38N4SbF6: C, 47.79; H, 5.08; N, 7.43.
Found: C, 48.34; H, 5.18; N, 6.99.
[(iPr3TACDD)Cu]SbF6. This was prepared analogously to [(iPr3-
TACD)Cu(CH3CN)]SbF6, except by using iPr3TACDD in CH2Cl2
1
(74%). H NMR (CD2Cl2, 300 MHz): δ 1.21 (d, J ) 6.6 Hz, 18H),
1.76-1.98 (m, 6H), 2.74 (qd, J ) 2.4, 7.2 Hz, 6H), 2.94 (qd, J ) 2.4,
8.1 Hz, 6H), 3.20 (h, J ) 6.6 Hz, 3H) ppm. 13C{1H} NMR (CDCl3, 75
MHz): δ 56.1, 56.0, 25.8, 18.6 ppm. Anal. Calcd for C18H39CuF6N3-
Sb: C, 36.22; H, 6.59; N, 7.04. Found: C, 36.47; H, 6.61; N, 7.09.